Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 222Carcinoma, Non-Small-Cell Lung 219Prostatic Neoplasms 156Multiple Myeloma 142Neoplasms 133Colorectal Neoplasms 118Leukemia, Myeloid, Acute 110Lung Neoplasms 103Neoplasm Metastasis 96Squamous Cell Carcinoma of Head and Neck 91Carcinoma, Hepatocellular 86Lymphoma 81Melanoma 78Pancreatic Neoplasms 74Triple Negative Breast Neoplasms 72Ovarian Neoplasms 66Sarcoma 65Lymphoma, Large B-Cell, Diffuse 61Carcinoma, Renal Cell 61Brain Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Head and Neck Neoplasms 57Recurrence 56Lymphoma, Non-Hodgkin 55Stomach Neoplasms 53Leukemia, Lymphocytic, Chronic, B-Cell 52Hematologic Neoplasms 52Endometrial Neoplasms 50Small Cell Lung Carcinoma 48Urinary Bladder Neoplasms 46

Interventions

N-monoacetylcystine 1Inhalation 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Attention Deficit Disorder with Hyperactivity × 90 days × Clear all
NCT04481048 2026-06-05

DoDNAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
25 enrolled 12 charts
CNS

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡